WCLC 2024 Insights: Optimal Management of Malignant Pleural Effusion

Insights from 2024 WCLC

P. Lee

Nodules and Lung Cancer Screening

Fox Chase Cancer Center

R. Kumar

Year in Review 2024 - Small Cell Lung Cancer

Nebraska Oncology Society

J. Murray

Thoracic Malignancies From an Interventional Pulmonologist's Perspec…

Fox Chase Cancer Center

C. Manley

Rad Onc 101: Radiation Oncology Basics

Nina Niu Sanford

N. Sanford

Year in Review 2024 - Key Trials and Progress in SCLC Treatment

Oncology 2024 Year in Review

N. Seetharamu

1L IO Advances in ES-SCLC Treatment

Fox Chase Cancer Center

A. Chiang

Side Effects of Tarlatamab for SCLC and How They Can Be Monitored at…

GRACE

I. Dagogo-Jack, M. Shields, A. Cooper

SCLC Overview: Neuroendocrine Subtypes & Treatment

GRACE

M. Shields

An Update of ADC Toxicities in Solid Tumors

OncoAlert

M. Lustberg

Tarlatamab: A Bispecific T-Cell Engager (BiTE®) Targeting DLL3 for R…

Myung-Ju Ahn

Lung Cancer Screening Guidelines and Care

Yale Cancer Center

E. Winer, L. T Tanoue

Regimen for LS-SCLC and Upfront Combo Therapy for EGFR-Mutant Lung C…

GRACE

I. Dagogo-Jack, J. Rotow, M. Shields, A. Cooper, A. Qin

ADCs in SCLC: Overview and Treatment

GRACE

M. Shields, A. Cooper

ASCO® 2024 Lung Cancer Highlights: Top Abstracts Including BEAT-SC, …

2024 ASCO® Annual Meeting Insights Hub

B. Halmos

NSCLC & SCLC Key Radiotherapy Updates From 2024

OncoAlert

H. Willers, K. Keane

Overview of ES/LS-SCLC & New Data

Integrity CE

A. Patel, M. Baumgart, S. Liu, G. Dy

SCLC: Treatment Overview and Treatment Landscape of Limited Stage

GRACE

M. Shields

ASCO® 2024 Lung Cancer Highlights: CROWN, LAURA, ADRIATIC, and PALOM…

2024 ASCO® Annual Meeting Insights Hub

L. Raez

SCLC Treatment Evolution - Debunking Myths, IO Advances, and Long-Te…

2024 ASCO® Annual Meeting Insights Hub

A. Chiang